Alk Abello A/S (ALKb.CO)

ALKb.CO on Copenhagen Stock Exchange

800.00DKK
23 Jul 2014
Price Change (% chg)

kr.-10.00 (-1.23%)
Prev Close
kr.810.00
Open
kr.810.00
Day's High
kr.811.00
Day's Low
kr.800.00
Volume
5,197
Avg. Vol
12,488
52-wk High
kr.870.00
52-wk Low
kr.447.50

ALKb.CO

Chart for ALKb.CO

About

Alk Abello A/S is a Denmark-based company active within the pharmaceutical industry. It is engaged in the development and marketing of pharmaceutical products for the treatment, prevention and diagnosis of allergy. Its product portfolio comprises allergy vaccines, emergency treatments and allergy diagnostics products. The... (more)

Overall

Beta: 0.33
Market Cap (Mil.): kr.7,458.16
Shares Outstanding (Mil.): 9.21
Dividend: 5.00
Yield (%): 0.62

Financials

  ALKb.CO Industry Sector
P/E (TTM): 60.51 35.48 35.85
EPS (TTM): 13.39 -- --
ROI: 4.54 18.97 18.25
ROE: 5.59 19.75 19.12
Search Stocks

UPDATE 2-NORDIC STOCKS - Factors to watch on April 15

(Adds Aker Solutions, Alma Media and Norsk Hydro, updates H&M and SKF)

15 Apr 2014

UPDATE 1-Stallergenes wins U.S. go-ahead for Oralair allergy pill

* Merck and partner ALK Abello expected to launch rival drug this year

02 Apr 2014

Alk expects to launch new allergy tablet in U.S. in 2017

COPENHAGEN - Danish pharmaceutical group Alk Abello expects to start selling its new dust mite allergy tablet in Europe and Japan around the end 2015 with the U.S. market a further year behind, its Chief Executive told Reuters on Thursday.

20 Mar 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks